CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia

Summary

GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Russian pharmaceutical market was worth $29.6B in 2012, but declined to $22.7B by 2016 due to the devaluation of the Russian ruble during the Russian Financial Crisis (2014-2017). By 2018, the economy had recovered and the pharmaceutical market had grown to $26.8B. It is forecast to reach $38.5B by 2025 at a Compound Annual Growth Rate (CAGR) of 5.3%. The Russian pharmaceutical market faces stiff competition from generic drugs. In 2018, generic drugs accounted for 61.8% of sales of the retail commercial market, while original drugs accounted for 38.2%. In 2015, the medical devices market in Russia was worth $7.07B, which increased to $7.92B in 2019. It is expected to grow at a CAGR of 4.1% from 2019 to reach $10.07B in 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Russia, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Novartis, Pfizer, GlaxoSmithKline, and Pharmstandard.
- Profiles and SWOT analyses of the major players in the medical device market: Medtronic, Roche, Essilor, and Zimmer Biomet
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Russian healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Russia’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Russia’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership